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Background: We sought to characterize the cognitive function and neuropsychiatric symptoms in cerebral
radionecrosis (CRN) patients who have received conformal radiation for nasopharyngeal carcinoma.
Methods: A total of 40 patients treated with radiotherapy (RT) that developed CRN (RT + CRN), 40 patients treated
with radiotherapy that did not have CRN (RT-No-CRN), and 36 newly diagnosed untreated nasopharyngeal
carcinoma patients (No-RT) were recruited. The cognitive function and neuropsychiatric symptoms were evaluated
with Montreal cognitive assessment (MoCA), the mini-mental state examination (MMSE), activity of daily living scale
(ADL), neuropsychiatric inventory (NPI), Hamilton depression scale (HAMD) and Hamilton anxiety scale (HAMA).
Results: The RT + CRN group had the lowest mean MMSE, MoCA and ADL scores, while highest mean NPI, HAMD
and HAMA scores among the three patient groups (P < 0.05). Thirty (75%) of the RT + CRN patients were deemed
cognitively impaired by the MoCA compared with 9 (22.5%) by the MMSE (χ2 = 22.064; P < 0.001). Eighty-two percents
of subject in RT + CRN group experienced neuropsychiatric symptoms within the past 4 weeks. Irritability, anxiety,
depression and agitation in the RT + CRN group were of the most significantly frequent among the 3 groups.
Conclusions: The CRN patients generally have manifestations in cognitive and psychological impairment, which have
their typical characteristics, and should be considered in CRN treatment and rehabilitation. The MoCA classifies more
CRN patients as cognitively impaired than the MMSE, justifying further studies of the MoCA as an appropriate screen
for CRN.
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Radiotherapy (RT) is the main treatment modality for
nasopharyngeal carcinoma (NPC) and has produced ex-
cellent outcomes in terms of survival rate [1]. To reach
satisfactory local control, the radiation field extends from
the skull base to the lower neck and a total dose of about
70Gy is generally required. In these cases, some important
normal structures, including the brain, are exposed to
the high dose radiation, and side effects are inevitable.
One possible severe consequence is the occurrence of
cerebral radionecrosis (CRN), which has an incidence rate
of 3.6% ~ 8.3% in different reports [2,3]. CRN is usually* Correspondence: hhw2002@sohu.com
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reproduction in any medium, provided the orirreversible and may progress over time [4]. The risk is
highest in the first 6 months to 3 years after irradiation,
but can persist for decades [5,6]. CRN is neuropatholo-
gically defined as necrosis with severe vascular lesions
(stenosis, thrombosis, haemorrhage, fibrinoid vascular
necrosis) [5]. Among patients after RT of NPC, the tem-
poral lobes are most frequently involved [7]. The outcome
varies from focal neurologic deficits to death. By using
MRI, the lesion can be manifested as the early finger-like
T2-hyperintensity area representative of reactive white
matter edema and the late cyst-like changes corroborating
with liquefactive necrosis and surrounding gliosis [8,9].
A major manifestation of CRN is the development of
cognitive and neuropsychiatric impairment. Patients usually
exhibit cognitive dysfunction ranges from inattention,
impaired short term memory, bradyphrenia, to frank. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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symptoms. Cognitive and neuropsychiatric impairment
have been recognized as a significant problem in CRN
patients. There is, however, a paucity of research in this
population. The objective of this study was to characterize
cognitive impairment and neuropsychiatric symptoms in
CRN patients who have received conformal radiation for
NPC, and also to develop a sensitive instrument for
routine screening. In addition, it is known that cognitive
and neuropsychiatric deficits are correlated significantly
with the development of CRN. Therefore, it might be of
clinical significance to determine the cognitive and neuro-
psychiatric function on the early diagnosis of CRN.Methods
Patients
From January 2011 to October 2011, eighty patients vol-
untarily participated in this study. They were recruited
from the First Affiliated Hospital of Sun Yat-Sen University
and Sun Yat-Sen University cancer center in Guangzhou.
These patients had received a radical course of conven-
tional radiotherapy for NPC between 1998 and 2010. The
irradiation dose was 68 to 74 Gy with a fraction dose of
2.0 Gy. RT was completed more than 1 year before the
patients were recruited. Characteristics of the patients at
baseline are listed in Table 1. A total of 36 newly diagnosed
untreated NPC patients (No-RT) were included as control
subjects. They matched the post-RT patients by some
factors including age, gender and education years. Pa-
tients with brain metastasis, a second history of RT in
head-and-neck cancer, history of head injury, history of
concurrent chemoradiotherapy, with other neurological or
mental diseases, and with impairments in vision, hearing
or motor function that prevent them from participating in
cognitive testing were excluded. The study was under-
taken in accordance with the principles of the Declaration
of Helsinki. The protocol was approved by the ethics com-
mittees of First Affiliated Hospital of Sun Yat-Sen University.
The patients and their caregivers provided written in-
formed consent.Table 1 Patient characteristics
Variable No-RT RT-No-CRN RT + CRN
(n = 36) (n = 40) (n = 40)
Age (y) 45.5 ± 8.6 47.3 ± 9.4 48.3 ± 9.7
Gender (No. M/F) 26:10 29:11 24:16
Education (y) 9.4 ± 2.8 10.4 ± 2.9 10.3 ± 3.0
Age at the completion of RT (y) - 43.5 ± 10.0 43.9 ± 9.2
Post-RT interval (y) - 3.8 ± 2.6 4.3 ± 2.9
Total RT dosage (Gy) 70.5 ± 2.0 70.7 ± 1.6
CTCAE grade (1/2/3/4/5) (No.) 4/18/13/5/0Of the 80 patients, 40 showed positive CRN findings
on MR imaging in the follow-up after radiotherapy
(RT + CRN), with gross hypointensity in T1-weighted
images, hyperintensity in T2-weighted images and hetero-
geneous contrast enhancement in gadolinium-enhanced
T1-weighted images on either or both hemispheres, which
indicated the presence of edema or cysts. Figure 1 illustrates
representative images of the T2-weighted and gadolinium-
enhanced T1-weighted MR images of a patient with CRN.
The remaining 40 patients did not exhibit signs referable
to the brain, resulting in negative findings on MR imaging
(RT-No-CRN). National Cancer Institute Common Ter-
minology Criteria for Adverse Events Version 4.0 (CTCAE
v 4.0) grade was obtained from patient records [10].Neuropsychological testing
The Mini Mental State Examination (MMSE) [11], Mon-
treal Cognitive Assessment (MoCA) (Beijing version) and
Activity of Daily Living Scale (ADL) [12] were used to
evaluate the general cognitive function. Both MMSE and
MoCA were widely used cognitive screens, and MoCA
has previous been documented to have superior sensitivity
in brain tumor patients [13,14]. The time to administer
each test was recorded. Impairment on the MMSE was
defined as a score below 17 to illiterate patients, 20 to
primary school culture patients, and 24 to individuals
with more than 6 years of education. Cutoff scores for
the MoCA was determined at 26 (scores of 25 or below
will indicate impairment), as defined by the MoCA’s
author [15]. A bonus point was given to individuals
with <12years of education on MoCA. Neuropsychiatric
inventory (NPI) [16], Hamilton depression scale (HAMD),
and Hamilton anxiety scale (HAMA) were used to evalu-
ate the neuropsychiatric symptoms. Trained research staff
administered these assessment scales in counterbalanced
manner.Figure 1 Cerebral radionecrosis shown by magnetic resonance
imaging. T2-weighted image showing finger-like edema in both
temporal lobes. Gadolinium-enhanced T1-weighted image of the
same patient showing heterogeneous contrast enhancement.
Table 2 Total scores of impairment on neuropsychological
tests
Variable No-RT RT-No-CRN RT + CRN *p
Value
†p
Value(n = 36) (n = 40) (n = 40)
MMSE 28.9 ± 1.9 28.6 ± 1.5 25.4 ± 4.6 <0.001 <0.001
Time to complete
MMSE (min)
4.0 ± 1.1 5.9 ± 1.7 5.7 ± 1.4 <0.001 0.886
MoCA 27.2 ± 2.2 27.2 ± 3.0 21.8 ± 5.3 <0.001 <0.001
Time to complete
MoCA (min)
6.4 ± 1.2 8.3 ± 2.3 8.1 ± 2.0 <0.001 1.000
ADL 20.0 ± 0 20.0 ± 0 23.7 ± 9.5 0.012 0.001
NPI 3.5 ± 6.7 3.5 ± 4.5 15.6 ± 17.0 <0.001 <0.001
HAMD 4.9 ± 4.1 2.9 ± 3.0 9.7 ± 6.3 <0.001 <0.001
HAMA 5.5 ± 4.1 3.8 ± 2.8 10.7 ± 7.8 <0.001 <0.001
Data are presented as mean ± SD.
*Comparison between the RT + CRN group and No-RT group.
†Comparison between the RT + CRN group and the RT-No-CRN group.
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Descriptive statistics were calculated for all variables. For
continuous variables, means and standard deviations were
calculated. Descriptive statistics for categorical variables
included the number and frequency in each category. Total
scores for MMSE, MoCA, ADL, NPI, HAMD and HAMA
were compared among the three groups using one-way
analysis of variance (ANOVA) models, followed by Bon-
ferroni test with significance level of 0.05. The chi square
test was used to determine if there was a significant differ-
ence in cognitive function between the RT +CRN and
RT-No-CRN group. The McNemar test was used to deter-
mine if there was a significant difference in the proportion
of CRN patients deemed cognitively impaired by the MMSE
and MoCA. MMSE and MoCA subdomain scores were
compared between the RT +CRN and RT-No-CRN group
using Wilcoxon rank sum test. Significance was defined as
P < 0.05. The NPI frequency of symptoms was dichoto-
mized (present or not) and compared between the three
groups with Fisher’s exact test. Analyses were carried out
with the SPSS, version 13.0.Table 3 MMSE and MOCA subdomain scores in the CRNResults
Subject characteristics
Table 1 shows the demographic and major clinical charac-
teristics of all subjects. There was no significant difference
in terms of age (F = 1.261; P = 0.285), gender (χ2 = 1.846;
P = 0.397) and level of education (F = 1.638; P = 0.197)
among the 3 patient groups. In addition, no significant
difference was found between RT +CRN and RT-No-CRN
patients in the mean total RT dosage (t = 0.562; P = 0.576),
age at the completion of RT (t = −0.291; P = 0.771) and
post-RT interval (t = −1.370; P = 0.172) (Table 1).and RT-No-CRN group
Variable RT-No-CRN RT + CRN p Value
(n = 40) (n = 40)
MMSE subdomain scores
Orientation 10.0 ± 0 9.6 ± 1.4 0.001
Registration 3.0 ± 0 2.6 ± 0.9 <0.001
Attention and calculation 4.3 ± 1.0 3.6 ± 1.7 0.002
Recall 2.5 ± 0.8 1.4 ± 1.3 <0.001
Language 8.8 ± 0.5 8.3 ± 1.2 <0.001
MoCA subdomain scores
Visuospatial and executive 3.8 ± 1.0 3.2 ± 1.5 0.038
Naming 2.9 ± 0.3 2.5 ± 0.8 <0.001
Attention 5.7 ± 0.5 5.0 ± 1.2 <0.001
Language 2.9 ± 0.3 2.3 ± 1.0 <0.001
Abstraction 1.6 ± 0.6 1.4 ± 0.8 0.112
Memory and delayed recall 3.5 ± 1.3 1.2 ± 1.4 <0.001
Orientation 6.0 ± 0 5.7 ± 0.8 0.001
MMSE and MOCA subdomain scores are presented as mean ± SD.Total scores of impairment on neuropsychological tests
The results of test are presented in Table 2. The RT +CRN
group had the lowest mean MMSE and MoCA scores,
while highest mean ADL, NPI, HAMD and HAMA scores
among the three patient groups (P < 0.01). The RT +CRN
and RT-No-CRN groups spent more time in completing
MMSE compared with the No-RT group (P < 0.01), and
they also spent more time in completing MoCA (P < 0.01).
Compared to the RT-No-CRN group, the RT + CRN
patients had significant high rate of cognitive impairment
either deemed by the MoCA (75%, P = 0.001) or by
MMSE (22.5%, P = 0.002), according to the given cutoff
scores. In the RT + CRN group, thirty (75%) patients
were deemed cognitively impaired by the MoCA compared
with 9 (22.5%) by the MMSE (P < 0.001). Twenty-one
(70.0%) of the RT + CRN patients with a normal MMSE
were classified cognitively impaired by the MoCA. None
of these patients was classified cognitively impaired by the
MMSE while having a normal score on the MoCA.MMSE and MoCA subdomain scores
The MMSE and MoCA subdomain scores for the differ-
ent groups were summarized in Table 3. A significant
reduction in MMSE subdomain scores for registration,
recall, language, attention and calculation, and orientation
ability was evident in the RT +CRN group compared with
the RT-No-CRN groups (P < 0.01). Consistent with the
MMSE tests, the RT + CRN group had lower MoCA
subdomain scores in memory and delayed recall, naming,
attention, language, visuospatial/executive function, and
orientation ability compared with the RT-No-CRN groups
(P < 0.01).
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Table 4 shows the NPI frequency in three groups.
Eighty-two percents of subject with RT +CRN experienced
some NPI symptom within the past 4 weeks compared
with 60.0% of the RT-No-CRN group (P < 0.01). The most
frequent symptoms among the subjects with RT + CRN
were irritability (87.5%), anxiety (72.5%), depression (62.5%),
agitation (30.0%), apathy (30.0%) and night time behavior
disturbances (15.0%). Irritability, anxiety, depression and
agitation were significantly more frequent in the RT +
CRN compared with the RT-No-CRN group and NPC
group (P < 0.05). Apathy and night time behavior distur-
bances were significantly more frequent among the CRN
compared with the RT-No-CRN group (P < 0.05). The
RT-No-CRN group experienced more irritability than
the No-RT group. Only subjects with RT + CRN had
elation (8.6%), aberrant motor activity (8.6%), appetite
abnormalities (8.6%), delusions (5.0%), hallucinations
(5.0%) and disinhibition (5.0%).
Discussion
In this study, we have shown that the CRN patients who
have received conformal radiation for NPC generally have
manifestations in cognitive impairment and neuropsychi-
atric symptoms, and also found some typical characteristics
that have not been reported previously.
We found that the CRN patients had significant change
of cognitive function, mainly reflects in short term mem-
ory, delayed recall, language, attention, orientation, visuo-
spatial and executive function. The results of our study are
similar to those of Cheung [17,18] and Hsiao [19] despiteTable 4 Frequency of impairment on NPI (overall and individ
Variable No-RT RT-N
(n = 36) (n =
Presence of symptoms in past 4 weeks, n (%)










Aberrant motor activity 0(0) 0
Night-time behavior disturbances 2(5.6) 0
Appetite/eating abnormalities 0(0) 0
*Comparison between the No-RT group and RT-No-CRN group.
†Comparison between the No-RT group and RT + CRN group.
‡Comparison between the RT-No-CRN group and RT + CRN group.methodological differences. In these studies, RT had dele-
terious effects on cognitive function in NPC patients. For
example, Cheung examined a group of NPC patients who
had completed their radiotherapy previously, and found
memory, language, motor ability, as well as executive func-
tions were significantly impaired for those patients who
developed temporal lobe necrosis after RT. Lesion volume
was correlated significantly with the severity of cognitive
deficits. Hsiao found that the cognitive functioning scores
had significantly declined in the domains of short-term
memory, language abilities, and list-generating fluency to
patients at least 1year after completion of RT.
We also found a relatively high rate of general in-
telligence impairment among CRN patients, with 22.5% by
the MMSE and 75% by the MoCA so affected. This result
was inconsistent with Cheung`s study of remaining rela-
tively intact general intelligence by the MMSE in CRN
patients [18]. It is possibly related to a longer post-RT
interval of mean 4.3years and bigger total RT dosage of
mean 70.7 Gy in our cohort, compared with about 1 year
and 58.4 Gy in the former. It has been confirmed that post-
RT interval and total RT dosage are correlated with more
severe CRN as well as cognitive defect respectively [20].
Compared to the MMSE, the MoCA provided more
information in identification of cognitive impairment in
a cohort of CRN patients, and cost only about 8 minutes to
complete. It can be explained by the inclusion of subtests
that measure more demanding assessment of executive
function, visuospatial function, new learning, attention,
and information processing speed. This is one of the few
studies to assess the MoCA in NPC survivors with CRN.ual symptoms) in 3 groups





Value40) (n = 40)
60.0) 33(82.5) 0.354 <0.001 0.006
(0) 2(5.0) - 0.209 0.209
(0) 2(5.0) - 0.209 0.209
7.5) 25(62.5) 0.407 0.002 <0.001
37.5) 29(72.5) 0.815 0.007 0.001
7.5) 12(30.0) 0.620 0.003 0.009
(0) 3(8.6) - 0.093 0.093
(0) 2(5.0) - 0.209 0.209
55.0) 35(87.5) 0.002 <0.001 0.001
0.0) 12(30.0) 1.000 0.053 0.023
(0) 3(8.6) - 0.093 0.093
(0) 6(15.0) 0.209 0.259 0.007
(0) 3(8.6) - 0.093 0.093
Wu et al. BMC Neurology 2014, 14:10 Page 5 of 6
http://www.biomedcentral.com/1471-2377/14/10Because the MoCA was so well tolerated and disagreed
with the MMSE in such a significant proportion of subjects,
we believe that the MoCA is a more sensitive CRN-related
cognitive screen suitable for clinical practice [21]. However,
this study is limited by the lack of gold standard neuro-
psychological assessment, and a validation study further
testing this preliminary hypothesis is warranted.
Another notable finding here is that CRN subjects have
relatively more neuropsychiatric symptoms than those of
their cerebral normal counterparts. The most frequent
symptoms among subjects with CRN are irritability (87.5%),
anxiety (72.5%) and depression (62.5%), with about 1 in
3 displaying agitation and apathy. Irritability, anxiety,
depression, agitation, apathy and night-time behavior
disturbances are significantly more frequent among sub-
jects with CRN than those with normal MR image. Only
subjects with CRN had psychotic symptoms including hal-
lucinations and delusions.
The association between neuropsychiatric impairment
and CRN has been recognized for some time, although lack
of exact quantitative investigation. Nishimura reported
clinical findings such as mental deterioration and motor
abnormality in 12 NPC survivors with CRN [22]. Arm-
strong reported depression appears to increase years after
RT, possibly first peaking somewhere between 4 and 6
years posttreatment [23]. Recently Tang examined a group
of CRN patients with Self-Rating Anxiety Scale and Self-
Rating Depression Scale, and found the patients with CRN
got higher scores in both scales [24]. This result was
consistent with our study of negative emotions in CRN
patients.
The temporal lobes that easily involved in CRN are
responsible for cognitive, emotional and psychological
function. Radiation-induced damage to progenitor popula-
tions responsible for maintenance of white matter integrity
and adult hippocampal neurogenesis has been suggested
to play a major role in the neurocognitive impairment
many cancer survivors experience [25]. The behavioral
and psychological manifestations may, in part, be related
to cerebral organic pathological changes (e.g., temporal
lobe, limbic system, hippocampus) [26-28], and also so-
cial psychological attack (including RT adverse reaction,
tumor deterioration) as well as cognitive dysfunction [29].
Post-RT patients, especially CRN victims, exhibit charac-
teristic irritability. Though the specific cause is yet to be
verified, attention should be paid to this syndrome in the
long term survivors to improve their quality of life.
CRN patients who have received conformal radiation
for NPC generally manifest cognitive neuropsychiatric
symptoms with typical characteristics. However the study
was limited by the relatively small sample size, and the lack
of statistical differences found between groups (i.e. abstrac-
tion, delusion, hallucination, and aberrant motor activity)
may not be a function of lack of differences, so that theresults should be confirmed in some larger sample size
and better match studies. Meanwhile, MoCA may be a
feasible instrument for routine cognitive screening, but
the sensitivity and specialty are not yet confirmed due
to lack of gold standard in the study.
Conclusions
In conclusion, we found that the CRN patients after RT for
NPC have relatively high level of cognitive impairment
and more frequent neuropsychiatric symptoms, which
have their typical characteristics. The development of
interventions to assist these persons in coping with such
symptoms should also be a goal for CRN treatment and
rehabilitation. The MoCA and NPI are feasible tests which
are suitable for clinical practice. MoCA classifies more
CRN patients as cognitively impaired than the MMSE,
which led us to the hypothesis that MoCA would be a
sensitive screen for CRN patients. Currently, this hypoth-
esis still needs further study to confirm, and such study is
now underway.
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